The global market for Azithromycin for Injection was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
North American market for Azithromycin for Injection was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Azithromycin for Injection was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Europe market for Azithromycin for Injection was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global key companies of Azithromycin for Injection include Pfizer, Luoxin Pharmaceuticals Group Stock Co., Ltd., Youcare Pharmaceutical, Zhejiang Better Pharmaceuticals Co., Ltd., Sichuan Kelun Pharmaceutical Co.,Ltd., Hainan Poly Pharm Co., Ltd., Qilu Pharmaceutical, Zhejiang Yatai Pharmaceutical Co., Ltd. and Hubei Keyi Pharmaceutical Co., Ltd., etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Azithromycin for Injection, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Azithromycin for Injection by region & country, by Type, and by Application.
The Azithromycin for Injection market size, estimations, and forecasts are provided in terms of sales volume (K Bottles) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Azithromycin for Injection.
Market Segmentation
By Company
Pfizer
Luoxin Pharmaceuticals Group Stock Co., Ltd.
Youcare Pharmaceutical
Zhejiang Better Pharmaceuticals Co., Ltd.
Sichuan Kelun Pharmaceutical Co.,Ltd.
Hainan Poly Pharm Co., Ltd.
Qilu Pharmaceutical
Zhejiang Yatai Pharmaceutical Co., Ltd.
Hubei Keyi Pharmaceutical Co., Ltd.
Zhejiang Conba Pharmaceutical Co.,Ltd.
CSPC Pharmaceutical Group Limited
Sun Pharma
Criticine Care
Eugia US
SteriMax Inc.
Medline Industries, Inc.
Aurobindo Pharma
Medizia Biotech
Segment by Type:
0.25g
0.5g
Segment by Application
Hospital
Clinic
Other
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Azithromycin for Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Azithromycin for Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Azithromycin for Injection in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Market Overview
1.1 Azithromycin for Injection Product Introduction
1.2 Global Azithromycin for Injection Market Size Forecast
1.2.1 Global Azithromycin for Injection Sales Value (2019-2030)
1.2.2 Global Azithromycin for Injection Sales Volume (2019-2030)
1.2.3 Global Azithromycin for Injection Sales Price (2019-2030)
1.3 Azithromycin for Injection Market Trends & Drivers
1.3.1 Azithromycin for Injection Industry Trends
1.3.2 Azithromycin for Injection Market Drivers & Opportunity
1.3.3 Azithromycin for Injection Market Challenges
1.3.4 Azithromycin for Injection Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Azithromycin for Injection Players Revenue Ranking (2023)
2.2 Global Azithromycin for Injection Revenue by Company (2019-2024)
2.3 Global Azithromycin for Injection Players Sales Volume Ranking (2023)
2.4 Global Azithromycin for Injection Sales Volume by Company Players (2019-2024)
2.5 Global Azithromycin for Injection Average Price by Company (2019-2024)
2.6 Key Manufacturers Azithromycin for Injection Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Azithromycin for Injection Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Azithromycin for Injection
2.9 Azithromycin for Injection Market Competitive Analysis
2.9.1 Azithromycin for Injection Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Azithromycin for Injection Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Azithromycin for Injection as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 0.25g
3.1.2 0.5g
3.2 Global Azithromycin for Injection Sales Value by Type
3.2.1 Global Azithromycin for Injection Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Azithromycin for Injection Sales Value, by Type (2019-2030)
3.2.3 Global Azithromycin for Injection Sales Value, by Type (%) (2019-2030)
3.3 Global Azithromycin for Injection Sales Volume by Type
3.3.1 Global Azithromycin for Injection Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Azithromycin for Injection Sales Volume, by Type (2019-2030)
3.3.3 Global Azithromycin for Injection Sales Volume, by Type (%) (2019-2030)
3.4 Global Azithromycin for Injection Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospital
4.1.2 Clinic
4.1.3 Other
4.2 Global Azithromycin for Injection Sales Value by Application
4.2.1 Global Azithromycin for Injection Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Azithromycin for Injection Sales Value, by Application (2019-2030)
4.2.3 Global Azithromycin for Injection Sales Value, by Application (%) (2019-2030)
4.3 Global Azithromycin for Injection Sales Volume by Application
4.3.1 Global Azithromycin for Injection Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Azithromycin for Injection Sales Volume, by Application (2019-2030)
4.3.3 Global Azithromycin for Injection Sales Volume, by Application (%) (2019-2030)
4.4 Global Azithromycin for Injection Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Azithromycin for Injection Sales Value by Region
5.1.1 Global Azithromycin for Injection Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Azithromycin for Injection Sales Value by Region (2019-2024)
5.1.3 Global Azithromycin for Injection Sales Value by Region (2025-2030)
5.1.4 Global Azithromycin for Injection Sales Value by Region (%), (2019-2030)
5.2 Global Azithromycin for Injection Sales Volume by Region
5.2.1 Global Azithromycin for Injection Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Azithromycin for Injection Sales Volume by Region (2019-2024)
5.2.3 Global Azithromycin for Injection Sales Volume by Region (2025-2030)
5.2.4 Global Azithromycin for Injection Sales Volume by Region (%), (2019-2030)
5.3 Global Azithromycin for Injection Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Azithromycin for Injection Sales Value, 2019-2030
5.4.2 North America Azithromycin for Injection Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Azithromycin for Injection Sales Value, 2019-2030
5.5.2 Europe Azithromycin for Injection Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Azithromycin for Injection Sales Value, 2019-2030
5.6.2 Asia Pacific Azithromycin for Injection Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Azithromycin for Injection Sales Value, 2019-2030
5.7.2 South America Azithromycin for Injection Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Azithromycin for Injection Sales Value, 2019-2030
5.8.2 Middle East & Africa Azithromycin for Injection Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Azithromycin for Injection Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Azithromycin for Injection Sales Value
6.2.1 Key Countries/Regions Azithromycin for Injection Sales Value, 2019-2030
6.2.2 Key Countries/Regions Azithromycin for Injection Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Azithromycin for Injection Sales Value, 2019-2030
6.3.2 United States Azithromycin for Injection Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Azithromycin for Injection Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Azithromycin for Injection Sales Value, 2019-2030
6.4.2 Europe Azithromycin for Injection Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Azithromycin for Injection Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Azithromycin for Injection Sales Value, 2019-2030
6.5.2 China Azithromycin for Injection Sales Value by Type (%), 2023 VS 2030
6.5.3 China Azithromycin for Injection Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Azithromycin for Injection Sales Value, 2019-2030
6.6.2 Japan Azithromycin for Injection Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Azithromycin for Injection Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Azithromycin for Injection Sales Value, 2019-2030
6.7.2 South Korea Azithromycin for Injection Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Azithromycin for Injection Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Azithromycin for Injection Sales Value, 2019-2030
6.8.2 Southeast Asia Azithromycin for Injection Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Azithromycin for Injection Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Azithromycin for Injection Sales Value, 2019-2030
6.9.2 India Azithromycin for Injection Sales Value by Type (%), 2023 VS 2030
6.9.3 India Azithromycin for Injection Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Pfizer
7.1.1 Pfizer Company Information
7.1.2 Pfizer Introduction and Business Overview
7.1.3 Pfizer Azithromycin for Injection Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Pfizer Azithromycin for Injection Product Offerings
7.1.5 Pfizer Recent Development
7.2 Luoxin Pharmaceuticals Group Stock Co., Ltd.
7.2.1 Luoxin Pharmaceuticals Group Stock Co., Ltd. Company Information
7.2.2 Luoxin Pharmaceuticals Group Stock Co., Ltd. Introduction and Business Overview
7.2.3 Luoxin Pharmaceuticals Group Stock Co., Ltd. Azithromycin for Injection Sales, Revenue and Gross Margin (2019-2024)
7.2.4 Luoxin Pharmaceuticals Group Stock Co., Ltd. Azithromycin for Injection Product Offerings
7.2.5 Luoxin Pharmaceuticals Group Stock Co., Ltd. Recent Development
7.3 Youcare Pharmaceutical
7.3.1 Youcare Pharmaceutical Company Information
7.3.2 Youcare Pharmaceutical Introduction and Business Overview
7.3.3 Youcare Pharmaceutical Azithromycin for Injection Sales, Revenue and Gross Margin (2019-2024)
7.3.4 Youcare Pharmaceutical Azithromycin for Injection Product Offerings
7.3.5 Youcare Pharmaceutical Recent Development
7.4 Zhejiang Better Pharmaceuticals Co., Ltd.
7.4.1 Zhejiang Better Pharmaceuticals Co., Ltd. Company Information
7.4.2 Zhejiang Better Pharmaceuticals Co., Ltd. Introduction and Business Overview
7.4.3 Zhejiang Better Pharmaceuticals Co., Ltd. Azithromycin for Injection Sales, Revenue and Gross Margin (2019-2024)
7.4.4 Zhejiang Better Pharmaceuticals Co., Ltd. Azithromycin for Injection Product Offerings
7.4.5 Zhejiang Better Pharmaceuticals Co., Ltd. Recent Development
7.5 Sichuan Kelun Pharmaceutical Co.,Ltd.
7.5.1 Sichuan Kelun Pharmaceutical Co.,Ltd. Company Information
7.5.2 Sichuan Kelun Pharmaceutical Co.,Ltd. Introduction and Business Overview
7.5.3 Sichuan Kelun Pharmaceutical Co.,Ltd. Azithromycin for Injection Sales, Revenue and Gross Margin (2019-2024)
7.5.4 Sichuan Kelun Pharmaceutical Co.,Ltd. Azithromycin for Injection Product Offerings
7.5.5 Sichuan Kelun Pharmaceutical Co.,Ltd. Recent Development
7.6 Hainan Poly Pharm Co., Ltd.
7.6.1 Hainan Poly Pharm Co., Ltd. Company Information
7.6.2 Hainan Poly Pharm Co., Ltd. Introduction and Business Overview
7.6.3 Hainan Poly Pharm Co., Ltd. Azithromycin for Injection Sales, Revenue and Gross Margin (2019-2024)
7.6.4 Hainan Poly Pharm Co., Ltd. Azithromycin for Injection Product Offerings
7.6.5 Hainan Poly Pharm Co., Ltd. Recent Development
7.7 Qilu Pharmaceutical
7.7.1 Qilu Pharmaceutical Company Information
7.7.2 Qilu Pharmaceutical Introduction and Business Overview
7.7.3 Qilu Pharmaceutical Azithromycin for Injection Sales, Revenue and Gross Margin (2019-2024)
7.7.4 Qilu Pharmaceutical Azithromycin for Injection Product Offerings
7.7.5 Qilu Pharmaceutical Recent Development
7.8 Zhejiang Yatai Pharmaceutical Co., Ltd.
7.8.1 Zhejiang Yatai Pharmaceutical Co., Ltd. Company Information
7.8.2 Zhejiang Yatai Pharmaceutical Co., Ltd. Introduction and Business Overview
7.8.3 Zhejiang Yatai Pharmaceutical Co., Ltd. Azithromycin for Injection Sales, Revenue and Gross Margin (2019-2024)
7.8.4 Zhejiang Yatai Pharmaceutical Co., Ltd. Azithromycin for Injection Product Offerings
7.8.5 Zhejiang Yatai Pharmaceutical Co., Ltd. Recent Development
7.9 Hubei Keyi Pharmaceutical Co., Ltd.
7.9.1 Hubei Keyi Pharmaceutical Co., Ltd. Company Information
7.9.2 Hubei Keyi Pharmaceutical Co., Ltd. Introduction and Business Overview
7.9.3 Hubei Keyi Pharmaceutical Co., Ltd. Azithromycin for Injection Sales, Revenue and Gross Margin (2019-2024)
7.9.4 Hubei Keyi Pharmaceutical Co., Ltd. Azithromycin for Injection Product Offerings
7.9.5 Hubei Keyi Pharmaceutical Co., Ltd. Recent Development
7.10 Zhejiang Conba Pharmaceutical Co.,Ltd.
7.10.1 Zhejiang Conba Pharmaceutical Co.,Ltd. Company Information
7.10.2 Zhejiang Conba Pharmaceutical Co.,Ltd. Introduction and Business Overview
7.10.3 Zhejiang Conba Pharmaceutical Co.,Ltd. Azithromycin for Injection Sales, Revenue and Gross Margin (2019-2024)
7.10.4 Zhejiang Conba Pharmaceutical Co.,Ltd. Azithromycin for Injection Product Offerings
7.10.5 Zhejiang Conba Pharmaceutical Co.,Ltd. Recent Development
7.11 CSPC Pharmaceutical Group Limited
7.11.1 CSPC Pharmaceutical Group Limited Company Information
7.11.2 CSPC Pharmaceutical Group Limited Introduction and Business Overview
7.11.3 CSPC Pharmaceutical Group Limited Azithromycin for Injection Sales, Revenue and Gross Margin (2019-2024)
7.11.4 CSPC Pharmaceutical Group Limited Azithromycin for Injection Product Offerings
7.11.5 CSPC Pharmaceutical Group Limited Recent Development
7.12 Sun Pharma
7.12.1 Sun Pharma Company Information
7.12.2 Sun Pharma Introduction and Business Overview
7.12.3 Sun Pharma Azithromycin for Injection Sales, Revenue and Gross Margin (2019-2024)
7.12.4 Sun Pharma Azithromycin for Injection Product Offerings
7.12.5 Sun Pharma Recent Development
7.13 Criticine Care
7.13.1 Criticine Care Company Information
7.13.2 Criticine Care Introduction and Business Overview
7.13.3 Criticine Care Azithromycin for Injection Sales, Revenue and Gross Margin (2019-2024)
7.13.4 Criticine Care Azithromycin for Injection Product Offerings
7.13.5 Criticine Care Recent Development
7.14 Eugia US
7.14.1 Eugia US Company Information
7.14.2 Eugia US Introduction and Business Overview
7.14.3 Eugia US Azithromycin for Injection Sales, Revenue and Gross Margin (2019-2024)
7.14.4 Eugia US Azithromycin for Injection Product Offerings
7.14.5 Eugia US Recent Development
7.15 SteriMax Inc.
7.15.1 SteriMax Inc. Company Information
7.15.2 SteriMax Inc. Introduction and Business Overview
7.15.3 SteriMax Inc. Azithromycin for Injection Sales, Revenue and Gross Margin (2019-2024)
7.15.4 SteriMax Inc. Azithromycin for Injection Product Offerings
7.15.5 SteriMax Inc. Recent Development
7.16 Medline Industries, Inc.
7.16.1 Medline Industries, Inc. Company Information
7.16.2 Medline Industries, Inc. Introduction and Business Overview
7.16.3 Medline Industries, Inc. Azithromycin for Injection Sales, Revenue and Gross Margin (2019-2024)
7.16.4 Medline Industries, Inc. Azithromycin for Injection Product Offerings
7.16.5 Medline Industries, Inc. Recent Development
7.17 Aurobindo Pharma
7.17.1 Aurobindo Pharma Company Information
7.17.2 Aurobindo Pharma Introduction and Business Overview
7.17.3 Aurobindo Pharma Azithromycin for Injection Sales, Revenue and Gross Margin (2019-2024)
7.17.4 Aurobindo Pharma Azithromycin for Injection Product Offerings
7.17.5 Aurobindo Pharma Recent Development
7.18 Medizia Biotech
7.18.1 Medizia Biotech Company Information
7.18.2 Medizia Biotech Introduction and Business Overview
7.18.3 Medizia Biotech Azithromycin for Injection Sales, Revenue and Gross Margin (2019-2024)
7.18.4 Medizia Biotech Azithromycin for Injection Product Offerings
7.18.5 Medizia Biotech Recent Development
8 Industry Chain Analysis
8.1 Azithromycin for Injection Industrial Chain
8.2 Azithromycin for Injection Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Azithromycin for Injection Sales Model
8.5.2 Sales Channel
8.5.3 Azithromycin for Injection Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
Pfizer
Luoxin Pharmaceuticals Group Stock Co., Ltd.
Youcare Pharmaceutical
Zhejiang Better Pharmaceuticals Co., Ltd.
Sichuan Kelun Pharmaceutical Co.,Ltd.
Hainan Poly Pharm Co., Ltd.
Qilu Pharmaceutical
Zhejiang Yatai Pharmaceutical Co., Ltd.
Hubei Keyi Pharmaceutical Co., Ltd.
Zhejiang Conba Pharmaceutical Co.,Ltd.
CSPC Pharmaceutical Group Limited
Sun Pharma
Criticine Care
Eugia US
SteriMax Inc.
Medline Industries, Inc.
Aurobindo Pharma
Medizia Biotech
听
听
*If Applicable.